Biotech Company With Clinical Operations Developing Psychedelic Medicine To Treat Addiction

First 3 UK Clinics Opened In 2021, Targeting 20 Clinics By 2024 ~$100M In Revenue

Free
Message: INTERVIEW ALERT: Awakn Life Sciences Corp., (AWKN: NEO) (AWKNF: OTCQB)

Looking for a #smallcap #psychedelics company with both clinics AND drug development pipeline?

$AWKNF is it

* 3 Clinics Launching UK / EU before end 21

* 20 clinics by 2024 = ~ $100M revenue

* Big research results OCT

OUT TONIGHT

Share
New Message
Please login to post a reply